Krsnaa Diagnostics reported Q1 FY27 consolidated revenue of ₹235.5 Cr, a strong 22% YoY growth, with EBITDA increasing 12% to ₹58.8 Cr.

However, Profit After Tax (PAT) declined 19% YoY to ₹16.6 Cr, mainly due to upfront fixed costs for new Rajasthan labs ahead of full utilization.

The retail segment is a standout, with revenue soaring 64% YoY to ₹19.3 Cr, now contributing 8% to total revenue, driven by a 75% rise in patient count and 47% in test volumes.

The company's strategy focuses on affordability, leveraging its Public-Private Partnership (PPP) infrastructure, and adopting AI-enabled diagnostics for efficiency.

Recent developments include doubling NABH-accredited centres to 66. Krsnaa aims to expand its retail footprint with 1,000+ centres and scale home collection services, building a sustainable cash business.